March 6, 2024

Osteoporosis is associated with anti-topoisomerase I positivity and glucocorticoids use in patients with systemic sclerosis

Key Points

Key points are not available for this paper at this time.

Abstract

Patients with systemic sclerosis (SSc) are at increased risk for osteoporosis (OP) and associated fragility fractures. This study aimed to identify underlying risk factors for these conditions in patients with SSc.

KI fragen

Bookmark

Cite This Study

Midol et al. (Wed,) studied this question.

synapsesocial.com/papers/68e7579cb6db6435876ceef5 https://doi.org/https://doi.org/10.1093/rheumatology/keae142

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Vertebral fracture prevalence and measurement of the scanographic bone attenuation coefficient on CT-scan in patients with systemic sclerosis2018 · 24 citations
2Trabecular Bone Score in Female Patients with Systemic Sclerosis: Comparison with Rheumatoid Arthritis and Influence of Glucocorticoid Exposure2014 · 56 citations
3Bone disease in systemic sclerosis: outcomes and associations.2015 · 16 citations
4Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status2011 · 56 citations
52014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis2014 · 135 citations

KI fragen

Bookmark